Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and Validation of an Assay to Quantify Plasma Circulating Tumor Human Papillomavirus DNA for 13 High-Risk Types that Cause 98% of HPV-Positive Cancers

25 Feb 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cervical Cancer and HPV Research
Share to Head and Neck Cancer Studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39998590
DOI: 10.1007/s12105-025-01752-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and Validation of an Assay to Quantify Plasma Circulating Tumor Human Papillomavirus DNA for 13 High-Risk Types that Cause 98% of HPV-Positive CancersPMID 39998590Read ↗

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverageSemantic proximity Read ↗

A comparison of the detection of biomarkers in infections due to low risk versus high-risk human papillomavirus typesSemantic proximity Read ↗

Molecular Diagnostics of Human PapillomavirusSemantic proximity Read ↗

Molecular detection and genotyping of human papillomavirus.Semantic proximity Read ↗

Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV typesSemantic proximity Read ↗

Highly-multiplex detection of plasma cell-free human papillomavirus-16 DNA in oropharyngeal carcinoma.Semantic proximity Read ↗

Blood-based screening for HPV-associated cancersSemantic proximity Read ↗

Sensitive and Specific Droplet Digital PCR Assays for Circulating Tumor HPV DNA: Development, Validation, and Clinical Application in HPV-Associated Cancers.Semantic proximity Read ↗

A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic CharacterizationSemantic proximity Read ↗

Analytical and clinical performance validation of HPV-SEQ, a novel NGS-based liquid biopsy platform for detection and quantification of human papilloma virus circulating tumor DNASemantic proximity Read ↗

Comparing the Diagnostic Performance of qPCR, ddPCR, and NGS Liquid Biopsies for HPV-Associated CancersSemantic proximity Read ↗

HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.